Additionally, studies have reported that over 70% of individuals with respiratory-onset ALS harbor ERBB4 insertions, compared to 25% in the general population, indicating that structural variations in ERBB4 may also influence the site of disease onset (Al et al., 2022). Here, ERBB4 is linked to Onset.